Cargando…

SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan

Hyponatremia (Na ˂135 mmol/l) is the most frequent electrolyte disorder in clinical practice, and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the commonest cause of hyponatremia in cancer patients. Correcting hyponatremia in these patients can reduce morbidity and mortali...

Descripción completa

Detalles Bibliográficos
Autores principales:	De las Peñas, Ramón, Ponce, Santiago, Henao, Fernando, Camps Herrero, Carlos, Carcereny, Enric, Escobar Álvarez, Yolanda, Rodríguez, César A., Virizuela, Juan Antonio, López López, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669367/ https://www.ncbi.nlm.nih.gov/pubmed/26431960 http://dx.doi.org/10.1007/s00520-015-2948-6

Ejemplares similares

Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia Resulting from SIADH Following Pituitary Surgery
por: Kleindienst, Andrea, et al.
Publicado: (2020)

THU239 Tolvaptan For SIADH Management In Children
por: Igarashi, Mizuho, et al.
Publicado: (2023)

A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan
por: Petereit, Claudia, et al.
Publicado: (2013)

The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases
por: Ren, Peng, et al.
Publicado: (2021)

Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADH
por: Willemsen, Ruben H, et al.
Publicado: (2016)

Long-term low-dose tolvaptan efficacy and safety in SIADH
por: Bondanelli, Marta, et al.
Publicado: (2023)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Guillain–Barré syndrome hyponatremia: is it SIADH or pseudohyponatremia?
por: Zemke, Anna M, et al.
Publicado: (2018)

Hyponatremia in children with pneumonia rarely means SIADH
por: Tagarro, Alfredo, et al.
Publicado: (2018)

Severe hyponatremia due to trimethoprim-sulfamethoxazole-induced SIADH
por: Marak, Creticus, et al.
Publicado: (2022)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis
por: Humayun, Malik Asif, et al.
Publicado: (2017)

Brucellosis manifesting as reversible ataxia caused by SIADH-related hyponatremia
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Management of hyponatremia associated with acute porphyria—proposal for the use of tolvaptan
por: Solares, Isabel, et al.
Publicado: (2020)

Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19
por: Habib, Mhd Baraa, et al.
Publicado: (2020)

Hyponatremia in COVID-19 infection: One should think beyond SIADH
por: Anand, Utpal, et al.
Publicado: (2021)

A case report of severe hyponatremia secondary to Paxlovid‐induced SIADH
por: Mohamed, Sarah, et al.
Publicado: (2023)

Case Report: Long-Term Tolvaptan Treatment in a Child With SIADH and Suprasellar Arachnoid Cyst
por: Puma, Andrea, et al.
Publicado: (2021)

Hyponatremia in a patient with meningitis and Crohn disease: Cerebral salt wasting or SIADH?
por: Yilmaz, Resul, et al.
Publicado: (2009)

Is inappropriate secretion of anti-diuretic hormone (SIADH) the cause of hyponatremia in Legionella pneumonia?
por: Schuetz, P, et al.
Publicado: (2012)

CSWS Versus SIADH as the Probable Causes of Hyponatremia in Children With Acute CNS Disorders
por: SORKHI, Hadi, et al.
Publicado: (2013)

SARS-CoV-2-induced SIADH: a novel cause of hyponatremia
por: Kleybolte, Johannes, et al.
Publicado: (2021)

Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience
por: Park, Gun Ha, et al.
Publicado: (2018)

Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010)

Tolvaptan in the Treatment of Acute Hyponatremia Associated with Acute Kidney Injury
por: Gopinath, Shilpa, et al.
Publicado: (2013)

Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients
por: Umbrello, Michele, et al.
Publicado: (2016)

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
por: Wang, Shuzhen, et al.
Publicado: (2018)

Associations of hyponatremia and SIADH with increased mortality, young age and infection parameters in patients with tuberculosis
por: Bal, Christina, et al.
Publicado: (2022)

Edematous Hyponatremia Treated with Tolvaptan in a Patient with Amyotrophic Lateral Sclerosis
por: Kim, Gheun-Ho
Publicado: (2017)

A Case of Water Intoxication with Prolonged Hyponatremia Caused by Excessive Water Drinking and Secondary SIADH
por: Yamashiro, Mari, et al.
Publicado: (2013)

SIADH with Severe Hyponatremia in an Elderly Man with Herpes Zoster Infection: A Causal or Casual Association?
por: Foppiani, Luca
Publicado: (2018)

Severe Symptomatic Hyponatremia Secondary to Escitalopram-Induced SIADH: A Case Report with Literature Review
por: Raj, Rishi, et al.
Publicado: (2018)

Unpredictable Nature of Tolvaptan in Treatment of Hypervolemic Hyponatremia: Case Review on Role of Vaptans
por: Malhotra, Ishan, et al.
Publicado: (2014)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone
por: YAMAMOTO, Hiroka, et al.
Publicado: (2023)

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021)
por: Majem, Margarita, et al.
Publicado: (2022)

Correction to: SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021)
por: Majem, Margarita, et al.
Publicado: (2022)

Hyponatremia in COVID-19 Is Not Always Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH): A Case Series
por: Javaid, Muhammad M, et al.
Publicado: (2022)

Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone
por: Han, Sang Woong, et al.
Publicado: (2018)

Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study
por: Estilo, Alvin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u53ka1ucmsg66o4urtduitc7dk